T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
NCT05141058
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
OTHER
Sponsor class
Conditions
SARS-CoV-2 Infection
Interventions
BIOLOGICAL:
Coronavirus-specific T cell (CST)
Sponsor
Children's National Research Institute